210 related articles for article (PubMed ID: 18406197)
1. Frequency and treatment of depressive symptoms in a Parkinson's disease registry.
Althaus A; Becker OA; Spottke A; Dengler R; Schneider F; Kloss M; Eggert K; Oertel WH; Dillmann U; Herting B; Classen J; Dodel R
Parkinsonism Relat Disord; 2008 Dec; 14(8):626-32. PubMed ID: 18406197
[TBL] [Abstract][Full Text] [Related]
2. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study.
Nègre-Pagès L; Grandjean H; Lapeyre-Mestre M; Montastruc JL; Fourrier A; Lépine JP; Rascol O;
Mov Disord; 2010 Jan; 25(2):157-66. PubMed ID: 19950403
[TBL] [Abstract][Full Text] [Related]
3. Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease.
Ehrt U; Brønnick K; Leentjens AF; Larsen JP; Aarsland D
Int J Geriatr Psychiatry; 2006 Mar; 21(3):252-8. PubMed ID: 16477585
[TBL] [Abstract][Full Text] [Related]
4. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
[TBL] [Abstract][Full Text] [Related]
5. Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's disease.
Suzuki K; Miyamoto M; Miyamoto T; Okuma Y; Hattori N; Kamei S; Yoshii F; Utsumi H; Iwasaki Y; Iijima M; Hirata K
Parkinsonism Relat Disord; 2009 Jan; 15(1):15-9. PubMed ID: 18359262
[TBL] [Abstract][Full Text] [Related]
6. [Benchmarking in patient care: depression in Parkinson's disease].
Spottke A; Schneider F; Dodel R
Z Evid Fortbild Qual Gesundhwes; 2011; 105(5):383-8. PubMed ID: 21767798
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study.
Pedersen KF; Larsen JP; Alves G; Aarsland D
Parkinsonism Relat Disord; 2009 May; 15(4):295-9. PubMed ID: 18801696
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of major depression in Belgian parkinsonian patients.
Vanderheyden JE; Gonce M; Bourgeois P; Cras P; De Nayer AR; Flamez A; Supiot F; Donneau AF; Albert A; Berlaimont V;
Acta Neurol Belg; 2010 Jun; 110(2):148-56. PubMed ID: 20873444
[TBL] [Abstract][Full Text] [Related]
9. [Depression in Parkinson's disease. Part 1: epidemiology, signs and symptoms, pathophysiology and diagnosis].
Storch A; Ebersbach G; Fuchs G; Jost WH; Odin P; Reifschneider G; Bauer M
Fortschr Neurol Psychiatr; 2008 Dec; 76(12):715-24. PubMed ID: 19012223
[TBL] [Abstract][Full Text] [Related]
10. Potentially inappropriate management of depressive symptoms among Ontario home care clients.
Dalby DM; Hirdes JP; Hogan DB; Patten SB; Beck CA; Rabinowitz T; Maxwell CJ
Int J Geriatr Psychiatry; 2008 Jun; 23(6):650-9. PubMed ID: 18229883
[TBL] [Abstract][Full Text] [Related]
11. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
12. Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode.
Pintor L; Baillès E; Valldeoriola F; Tolosa E; Martí MJ; de Pablo J
Gen Hosp Psychiatry; 2006; 28(1):59-64. PubMed ID: 16377367
[TBL] [Abstract][Full Text] [Related]
13. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
Devos D; Dujardin K; Poirot I; Moreau C; Cottencin O; Thomas P; Destée A; Bordet R; Defebvre L
Mov Disord; 2008 Apr; 23(6):850-7. PubMed ID: 18311826
[TBL] [Abstract][Full Text] [Related]
14. Impulse control disorders and depression in Finnish patients with Parkinson's disease.
Joutsa J; Martikainen K; Vahlberg T; Voon V; Kaasinen V
Parkinsonism Relat Disord; 2012 Feb; 18(2):155-60. PubMed ID: 21983019
[TBL] [Abstract][Full Text] [Related]
15. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
[TBL] [Abstract][Full Text] [Related]
16. [Depressive symptoms and motor condition in Parkinson's disease patients].
Stella F; Bucken-Gobbi LT; Gobbi S; Sant'Ana-Simões C
Rev Neurol; 2007 Nov 16-30; 45(10):594-8. PubMed ID: 18008264
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and correlates of neuropsychiatric symptoms in a population with Parkinson's disease in Mexico.
Ringman JM; Diaz-Olavarrieta C; Rodriguez Y; Fairbanks L; Cummings JL
Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):99-105. PubMed ID: 12050472
[TBL] [Abstract][Full Text] [Related]
18. Depression in patients with Parkinson's disease: impact on functioning.
Stella F; Banzato CE; Barasnevicius Quagliato EM; Viana MA
J Neurol Sci; 2008 Sep; 272(1-2):158-63. PubMed ID: 18589453
[TBL] [Abstract][Full Text] [Related]
19. Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease.
Lemke MR; Brecht HM; Koester J; Reichmann H
J Neurol Sci; 2006 Oct; 248(1-2):266-70. PubMed ID: 16814808
[TBL] [Abstract][Full Text] [Related]
20. Treatment with antiparkinson and antidepressant drugs: a register-based, pharmaco-epidemiological study.
Brandt-Christensen M; Kvist K; Nilsson FM; Andersen PK; Kessing LV
Mov Disord; 2007 Oct; 22(14):2037-42. PubMed ID: 17853463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
